Precision medicine’s next frontier: Unlocking the power of biospecimens

In conversation with Fierce Biotech, Austin Read, head of PPD™ CorEvitas™ Precision Medicine unpacks the evolving landscape of precision therapeutic and diagnostic development.

Watch the video to discover:

• How linking biospecimens with longitudinal patient data from registries is transforming translational medicine beyond oncology and rare disease
• The importance of ethical considerations, operational design and data quality in biospecimen collection and use
• AI-driven innovations that offer key opportunities for accelerating research

Watch the full interview to hear insights on how these advances are reshaping patient care and the future of precision medicine.